Yuan J, Bi XW, Hua X, Huang H, et al. Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial. Lancet Oncol 2025;26:1575-1583.
PMID: 41308674